Numinus to Participate in the KCSA Mental Health Virtual Investor Conference on December 15, 2022 Post published:December 21, 2022 Post category:Press Release
Numinus Wellness Inc. Reports Q4 2022 and Annual Results Post published:December 2, 2022 Post category:Press Release
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, December 8, 2022 Post published:November 23, 2022 Post category:Press Release
Numinus Re-Launches “Psychedelic Therapy Frontiers” Podcast with additional hosts and topics Post published:November 1, 2022 Post category:Press Release
Numinus to Participate in Wonderland: Miami on November 3-5, 2022 Post published:October 31, 2022 Post category:Press Release
Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness Post published:October 28, 2022 Post category:Press Release
Numinus to Participate in a Water Tower Research Fireside Chat on Thursday, October 13, 2022 Post published:October 8, 2022 Post category:Press Release
Numinus Develops Mushroom Tea for Use in Psychedelic Research Post published:October 6, 2022 Post category:Press Release
Numinus to Participate in the Cantor Neurology & Psychiatry Conference on October 6-7, 2022 Post published:September 30, 2022 Post category:Press Release
Numinus Expands Ketamine Therapy for Mental Health in Montreal and announces new brand awareness initiatives USA – English USA – English USA – English España – español Latin America – español Post published:September 23, 2022 Post category:Press Release